{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T14:47:41Z","timestamp":1778942861637,"version":"3.51.4"},"reference-count":27,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reumatolog\u00eda Cl\u00ednica"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.reuma.2018.11.006","type":"journal-article","created":{"date-parts":[[2018,12,26]],"date-time":"2018-12-26T09:02:17Z","timestamp":1545814937000},"page":"455-461","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Valor diagn\u00f3stico de anticuerpos antip\u00e9ptido citrulinado del fibrin\u00f3geno en la artritis reumatoide"],"prefix":"10.1016","volume":"16","author":[{"given":"Goitybell","family":"Mart\u00ednez T\u00e9llez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B\u00e1rbara","family":"Torres Rives","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge Alexis","family":"G\u00f3mez Morej\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hilda","family":"P\u00e9rez Garay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio Melchor","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose \u00c1ngel","family":"Portal Miranda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.reuma.2018.11.006_bib0140","series-title":"Immunolog\u00eda celular y molecular","author":"Abbas","year":"2015"},{"key":"10.1016\/j.reuma.2018.11.006_bib0145","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nrrheum.2017.15","article-title":"Beyond citrullination: Other post-translational protein modifications in rheumatoid arthritis","volume":"13","author":"Trouw","year":"2017","journal-title":"Nat Rev Rheumatol."},{"key":"10.1016\/j.reuma.2018.11.006_bib0150","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s12041-014-0380-1","article-title":"Association of susceptible genetic markers and autoantibodies in rheumatoid arthritis","volume":"93","author":"Mohan","year":"2015","journal-title":"J Genet."},{"key":"10.1016\/j.reuma.2018.11.006_bib0155","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1136\/annrheumdis-2013-203915","article-title":"Identification of anticitrullinated protein antibody reactivity in a subset of anti-CCP-negative rheumatoid arthritis: Association with cigarette smoking and HLA-DRB1 \u2018shared epitope\u2019 alleles","volume":"74","author":"Wagner","year":"2015","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.reuma.2018.11.006_bib0160","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/rheumatology\/keu323","article-title":"The genetics of rheumatoid arthritis: Risk and protection in different stages of the evolution of RA","volume":"55","author":"Yarwood","year":"2016","journal-title":"Rheumatology."},{"key":"10.1016\/j.reuma.2018.11.006_bib0165","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.reuma.2013.02.008","article-title":"Osteoinmunologia: el estudio de la relaci\u00f3n entre el sistema inmune y el tejido \u00f3seo","volume":"9","author":"Arboleya","year":"2013","journal-title":"Reumatol Clin."},{"key":"10.1016\/j.reuma.2018.11.006_bib0170","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism association 1987. Revised criteria for the classification of Rheumatoid Arthritis","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.reuma.2018.11.006_bib0175","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"Rheumatoid arthritis classification criteria: An American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.reuma.2018.11.006_bib0180","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1172\/JCI1316","article-title":"Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies","volume":"101","author":"Schellenkens","year":"1988","journal-title":"J Clin Invest."},{"key":"10.1016\/j.reuma.2018.11.006_bib0185","first-page":"1","article-title":"Anti-citrullinated peptide antibodies are the strongest predictor of clinically relevant radiographic progression in rheumatoid arthritis patients achieving remission or low disease activity: A posthoc analysis of a nationwide cohort in Japan","volume":"12","author":"Koga","year":"2017","journal-title":"PLoS ONE 1."},{"key":"10.1016\/j.reuma.2018.11.006_bib0190","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/art.38017","article-title":"Anti-cyclic citrullinated peptide assays differ in subjects at elevated risk for rheumatoid arthritis and subjects with established disease","volume":"65","author":"Demoruelle","year":"2013","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.reuma.2018.11.006_bib0195","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1515\/cclm-2013-0798","article-title":"Meta-analysis: Diagnostic accuracy of anti-cyclic citrullinated peptide 2 antibody and anti-cyclic citrullinated peptide 3 antibody in rheumatoid arthritis","volume":"526","author":"Zhang","year":"2014","journal-title":"Clin Chem Lab Med."},{"key":"10.1016\/j.reuma.2018.11.006_bib0200","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s12026-013-8425-8","article-title":"Superior performance of the CCP3.1 test compared to CCP2 and MCV in the rheumatoid factor-negative RA population","volume":"56","author":"Szekanecz","year":"2013","journal-title":"Immunol Res."},{"key":"10.1016\/j.reuma.2018.11.006_bib0205","first-page":"1","article-title":"Importancia cl\u00ednica de los anticuerpos p\u00e9ptidos c\u00edclicos citrulinados en el diagn\u00f3stico de la artritis reumatoide","volume":"2","author":"Arana","year":"2015","journal-title":"ReIbCi."},{"key":"10.1016\/j.reuma.2018.11.006_bib0210","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1093\/rheumatology\/keq419","article-title":"The relevance of citrullinated vimentin in the production of antibodies against citrullinated proteins and the pathogenesis of rheumatoid arthritis","volume":"50","author":"Van Steendam","year":"2011","journal-title":"Rheumatology (Oxford)."},{"key":"10.1016\/j.reuma.2018.11.006_bib0215","series-title":"Laboratorio cl\u00ednico","author":"Suardiaz","year":"2007"},{"key":"10.1016\/j.reuma.2018.11.006_bib0220","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/art.1780380107","article-title":"Modified disease activity scores that include twentyeight-joint counts","volume":"38","author":"Prevoo","year":"1995","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.reuma.2018.11.006_bib0225","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1745-7580-2-2","article-title":"Improved method for predicting lineal B-cell epitopes","volume":"2","author":"Pontoppidan","year":"2006","journal-title":"Immunome Research."},{"key":"10.1016\/j.reuma.2018.11.006_bib0230","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1110\/ps.062405906","article-title":"Prediction of residues in discontinuous B cell epitopes using protein 3D structures","volume":"15","author":"Haste","year":"2006","journal-title":"Protein Sci."},{"key":"10.1016\/j.reuma.2018.11.006_bib0235","first-page":"117","article-title":"The fibrin-derived citrullinated peptide \u00df60-74Cit60,72,74 bears the major ACPA epitope recognised by the rheumatoid arthritis-specific anticitrullinated fibrinogen autoantibodies and anti-CCP2 antibodies","volume":"61","author":"Cornillet","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.reuma.2018.11.006_bib0240","doi-asserted-by":"crossref","first-page":"R135","DOI":"10.1186\/ar2802","article-title":"Diagnostic and prognostic value of antibodies against chimeric fibrin\/filaggrin citrullinated synthetic peptides in rheumatoid arthritis","volume":"11","author":"Sanmarti","year":"2009","journal-title":"Arthritis Res Ther."},{"key":"10.1016\/j.reuma.2018.11.006_bib0245","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1002\/eji.200535790","article-title":"Epitopes of human fibrin recognized by the rheumatoid arthritis-specific autoantibodies to citrullinated proteins","volume":"36","author":"Sebbag","year":"2006","journal-title":"Eur J Clin Immunol."},{"key":"10.1016\/j.reuma.2018.11.006_bib0250","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1080\/00365513.2016.1200133","article-title":"The dependency on neighboring amino acids for reactivity of anti-citrullinated protein antibodies to citrullinated proteins","volume":"76","author":"Dam","year":"2016","journal-title":"Scand J Clin Lab Investig."},{"key":"10.1016\/j.reuma.2018.11.006_bib0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0144707","article-title":"Contribution of peptide backbone to anti-citrullinated peptide antibody reactivity","volume":"10","author":"Trier","year":"2015","journal-title":"PLoS ONE."},{"key":"10.1016\/j.reuma.2018.11.006_bib0260","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s00296-016-3472-9","article-title":"Carbamylated vimentin represents a relevant autoantigen in Latin American (Cuban) rheumatoid arthritis patients","volume":"36","author":"Martinez","year":"2016","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.reuma.2018.11.006_bib0265","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1136\/annrheumdis-2012-202868","article-title":"The fibrin-derived citrullinated peptide \u00df60-74Cit60,72,74 bears the major ACPA epitope recognised by the rheumatoid arthritis-specific anticitrullinated fibrinogen autoantibodies and anti-CCP2 antibodies","volume":"73","author":"Cornillet","year":"2014","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.reuma.2018.11.006_bib0270","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s13075-017-1329-6","article-title":"Differing specificities and isotypes of anticitrullinated peptide\/protein antibodies in palindromic rheumatism and rheumatoid arthritis","volume":"19","author":"Cabrera-Villalba","year":"2017","journal-title":"Arthritis Res Ther."}],"container-title":["Reumatolog\u00eda Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1699258X18302584?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1699258X18302584?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T15:00:35Z","timestamp":1761663635000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1699258X18302584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S1699258X18302584"],"URL":"https:\/\/doi.org\/10.1016\/j.reuma.2018.11.006","relation":{},"ISSN":["1699-258X"],"issn-type":[{"value":"1699-258X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Valor diagn\u00f3stico de anticuerpos antip\u00e9ptido citrulinado del fibrin\u00f3geno en la artritis reumatoide","name":"articletitle","label":"Article Title"},{"value":"Reumatolog\u00eda Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reuma.2018.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}